BioCentury | Oct 6, 2003
Company News

VitaGen, Vital Therapies deal

...Vital acquired the assets of VitaGen, including its ELAD extracorporeal liver assist device and a manufacturing...
...program, which was halted in Phase II trials by VitaGen due to lack of funding. VitaGen Inc....
BioCentury | Aug 11, 2003
Company News

Spectral Genomics management update

...Supply/Service, Microarrays, Genomics Hired: Robert Johnson as president and COO, formerly CSO and COO of VitaGen Inc. WIR...
BioCentury | Apr 8, 2002
Company News

VitaGen management update

VitaGen Inc., La Jolla, Calif. Business: Gene/Cell therapy, Transplant Hired: Richard Piazza as CEO and a director, formerly president and CEO at Maxia Pharmaceuticals Inc. WIR Staff Transplant...
BioCentury | Apr 3, 2002
Company News

Piazza returns to VitaGen as CEO

...returned to metabolic company VitaGen (La Jolla, Calif.) as CEO and a director. Piazza left Vitagen...
...and CEO, and in 2001 joined Maxia Pharmaceuticals (San Diego, Calif.) as president and CEO. VitaGen...
BioCentury | Mar 18, 2002
Clinical News

ELAD Artificial Liver: Phase I/II data; Phase II

...ELAD-treated patients were successfully bridged to transplant or recovery versus 43% (3/7) in control group. VitaGen Inc....
BioCentury | Jan 7, 2002
Company News

VitaGen management update

VitaGen Inc., La Jolla, Calif. Business: Metabolic Hired: Mark D'Andrea as VP of manufacturing, formerly senior director of process development at Selective Genetics Inc. WIR Staff...
BioCentury | Jun 28, 2001
Financial News

VitaGen raises $15 million

VitaGen (San Diego, Calif.), which is in Phase I testing of its Extracorporeal Liver Assist Device (ELAD), raised $15 million in a private financing. Investors included JP Morgan Partners; BD Ventures; Merrill Lynch Ventures; Perseus...
BioCentury | Jun 19, 2000
Company News

VitaGen management update

VitaGen Inc., La Jolla, Calif. Business: Metabolic Hired: Angeline Shashlo as VP of regulatory affairs and quality assurance, formerly director of regulatory affairs and compliance at Ligand Pharmaceuticals Inc. WIR Staff...
BioCentury | Feb 14, 2000
Company News

VitaGen management update

VitaGen Inc., La Jolla, Calif. Business: Metabolic Hired: Greg Dane as CEO, formerly president and CEO of Neocrin Co. WIR Staff...
BioCentury | Sep 20, 1999
Company News

PharmaPrint management update

...Calif. Business: Nutraceuticals, Cancer Hired: C. Richard Piazza as president and CEO, formerly CEO of VitaGen Inc....
Items per page:
1 - 10 of 15
BioCentury | Oct 6, 2003
Company News

VitaGen, Vital Therapies deal

...Vital acquired the assets of VitaGen, including its ELAD extracorporeal liver assist device and a manufacturing...
...program, which was halted in Phase II trials by VitaGen due to lack of funding. VitaGen Inc....
BioCentury | Aug 11, 2003
Company News

Spectral Genomics management update

...Supply/Service, Microarrays, Genomics Hired: Robert Johnson as president and COO, formerly CSO and COO of VitaGen Inc. WIR...
BioCentury | Apr 8, 2002
Company News

VitaGen management update

VitaGen Inc., La Jolla, Calif. Business: Gene/Cell therapy, Transplant Hired: Richard Piazza as CEO and a director, formerly president and CEO at Maxia Pharmaceuticals Inc. WIR Staff Transplant...
BioCentury | Apr 3, 2002
Company News

Piazza returns to VitaGen as CEO

...returned to metabolic company VitaGen (La Jolla, Calif.) as CEO and a director. Piazza left Vitagen...
...and CEO, and in 2001 joined Maxia Pharmaceuticals (San Diego, Calif.) as president and CEO. VitaGen...
BioCentury | Mar 18, 2002
Clinical News

ELAD Artificial Liver: Phase I/II data; Phase II

...ELAD-treated patients were successfully bridged to transplant or recovery versus 43% (3/7) in control group. VitaGen Inc....
BioCentury | Jan 7, 2002
Company News

VitaGen management update

VitaGen Inc., La Jolla, Calif. Business: Metabolic Hired: Mark D'Andrea as VP of manufacturing, formerly senior director of process development at Selective Genetics Inc. WIR Staff...
BioCentury | Jun 28, 2001
Financial News

VitaGen raises $15 million

VitaGen (San Diego, Calif.), which is in Phase I testing of its Extracorporeal Liver Assist Device (ELAD), raised $15 million in a private financing. Investors included JP Morgan Partners; BD Ventures; Merrill Lynch Ventures; Perseus...
BioCentury | Jun 19, 2000
Company News

VitaGen management update

VitaGen Inc., La Jolla, Calif. Business: Metabolic Hired: Angeline Shashlo as VP of regulatory affairs and quality assurance, formerly director of regulatory affairs and compliance at Ligand Pharmaceuticals Inc. WIR Staff...
BioCentury | Feb 14, 2000
Company News

VitaGen management update

VitaGen Inc., La Jolla, Calif. Business: Metabolic Hired: Greg Dane as CEO, formerly president and CEO of Neocrin Co. WIR Staff...
BioCentury | Sep 20, 1999
Company News

PharmaPrint management update

...Calif. Business: Nutraceuticals, Cancer Hired: C. Richard Piazza as president and CEO, formerly CEO of VitaGen Inc....
Items per page:
1 - 10 of 15